Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

202 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Completed

PRS-343 in HER2-Positive Solid Tumors

NCT03330561

Conditions
HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Los Angeles (UCLA) Santa Monica, California, United States
  • Georgetown University, Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
View Trial Details
Completed

PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors

NCT03650348

Conditions
HER2-positive Bladder Cancer, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, +1 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • UCLA Health Santa Monica, California, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View Trial Details
Completed

EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan

NCT05458401

Conditions
HER2-positive Breast Cancer
Locations
  • St. Vincent's Private Hospital Dublin, Ireland
  • St. Vincent's University Hospital Dublin, Ireland
  • Breast Center Humanitas Cancer Center IRCCS Istituto Clinico Humanitas Rozzano, Milano, Italy
  • Centro di riferimento Oncologico (CRO), National Cancer Institute Aviano, Pordenone, Italy
View all 21 locations
View Trial Details
Completed

A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer

NCT05769751

Conditions
HER2-positive Breast Cancer
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Zhejiang Cancer Hospital Hangzhou, China
  • Affiliated Cancer Hospital of Shandong First Medical University Jinan, China
  • Liaoning Cancer Hospital Shenyang, China
View Trial Details
Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details

Related conditions